Keith Woods - 16 Oct 2023 Form 3 Insider Report for X4 Pharmaceuticals, Inc (XFOR)

Role: Director
Signature: /s/ Adam S. Mostafa, attorney-in-fact
Issuer symbol: XFOR
Transactions as of: 16 Oct 2023
Net transactions value: $0
Form type: 3
Filing time: 18 Oct 2023, 16:00:40 UTC
Next filing: 08 Dec 2023
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit List: Exhibit 24 Power of Attorney